Government news, all in one place
Government news, all in one place
782 articles
Showing 181-210
Tuesday, 17 September 2024
New strategy aims to transform the way we provide information on the risks and safety of medicines and medical devices. ...
Thursday, 05 September 2024
Men taking valproate and their partners are being advised by the Medicines and Healthcare products Regulatory Agency (MHRA) to use effective contracep...
Tuesday, 03 September 2024
Following a thorough review, the Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the available evidence does not establi...
Monday, 02 September 2024
As the new school year looms, the MHRA sets out key advice on children's medicines and medical devices. ...
Sunday, 01 September 2024
The MHRA has approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant....
Thursday, 29 August 2024
Dr Junaid Bajwa, Professor Graham Cooke, Dr Paul Goldsmith and Rajakumari Long have had their appointments as Non-Executive Directors (NEDs) of th...
Thursday, 22 August 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 22 August 2024, approved a product licence for the medicine lecanemab (Leqem...
Wednesday, 14 August 2024
Zolbetuximab (Vyloy) is a monoclonal antibody that can recognise and attach itself to certain cancer cells to destroy them....
Tuesday, 13 August 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 17 July 2024, approved the medicine capivasertib (Truqap) for patients with ...
Sunday, 28 July 2024
Key advice on medicines and medical devices for the holiday season....
Tuesday, 23 July 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 24 July, approved an adapted Pfizer/BioNTech COVID-19 vaccine (Comirnaty) th...
Tuesday, 23 July 2024
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease...
Friday, 19 July 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 July 2024, approved the first generic raltegravir medicines to treat adul...
Wednesday, 17 July 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 17 July 2024, approved the medicine vibegron (Obgemsa) to treat the sympto...
Friday, 12 July 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new formulation of the medicine ocrelizumab (Ocrevus 920mg solution for ...
Monday, 01 July 2024
A man who had unlicensed medicines sent to his parents’ address, has been sentenced at Southwark Crown Court to a term of imprisonment, having earlier...
Thursday, 20 June 2024
Migraine and antiseizure medication topiramate must no longer be prescribed to women and girls unless they fulfil the requirements of a Pregnancy Prev...
Tuesday, 21 May 2024
This initiative signals an important step towards a new regulatory framework for medical devices in Great Britain which protects public health, ensure...
Tuesday, 21 May 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (21 May 2024) launched a four-week consultation which will support improved s...
Thursday, 16 May 2024
Backed by a new award of £1.8 million, the Medicines and Healthcare products Regulatory Agency (MHRA) is to establish a dedicated team to provide regu...
Thursday, 16 May 2024
Two pharmacists who sold ‘industrial’ quantities of Class C controlled drugs were yesterday sentenced to two years’ imprisonment each, suspended for 2...
Thursday, 09 May 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 May 2024) launched AI Airlock, its new regulatory sandbox for AI as a Medi...
Tuesday, 07 May 2024
An MHRA and NICE partnership, funded by Wellcome, is addressing key challenges for regulating and evaluating digital mental health technologies (DMHTs...
Friday, 03 May 2024
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months...
Tuesday, 30 April 2024
The MHRA has today set out its strategic approach to artificial intelligence (AI)...
Monday, 29 April 2024
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsych...
Monday, 29 April 2024
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects...
Tuesday, 09 April 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the gen...
Friday, 05 April 2024
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potenti...
Thursday, 04 April 2024
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)...
Environment Agency New plans for Guildford flood defence scheme to go on show
Department of Health and Social Care Healthcare innovator appointed to Health Data Research Service
HM Treasury Chancellor appoints Business Adviser
Traffic Commissioners for Great Britain Pushed past the limits
Foreign, Commonwealth & Development Office WTO General Council December 2025: UK Statement
Department for Transport New chairs of Network Rail and DFTO named
Home Office New rules on police requesting counselling notes come into force
Disclosure and Barring Service DBS launches new Customer Satisfaction Survey to improve services